Stockscreener 앱 받기
14.36
2.79%
0.39
전일 마감가:
$13.97
열려 있는:
$13.96
하루 거래량:
563.70K
Relative Volume:
1.43
시가총액:
$1.36B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+32.96%
1개월 성능:
-10.36%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$12.36
$14.88
1주일 범위
$11.38
$14.88
52주 변동 폭
$9.965
$19.45
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
Compare LMRI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LMRI
Lumexa Imaging Holdings Inc
|
14.36 | 1.32B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2026-01-05 | 개시 | Barclays | Overweight |
| 2026-01-05 | 개시 | Deutsche Bank | Buy |
| 2026-01-05 | 개시 | JP Morgan | Overweight |
| 2026-01-05 | 개시 | Jefferies | Buy |
| 2026-01-05 | 개시 | Leerink Partners | Outperform |
| 2026-01-05 | 개시 | Raymond James | Outperform |
| 2026-01-05 | 개시 | Wells Fargo | Overweight |
| 2026-01-05 | 개시 | William Blair | Outperform |
모두보기
Lumexa Imaging Holdings Inc 주식(LMRI)의 최신 뉴스
Wall Street Analysts Are Bullish on Top Technology Picks - The Globe and Mail
Lumexa Imaging (NASDAQ:LMRI) Rating Increased to Strong-Buy at Raymond James Financial - Defense World
LMRI Lumexa Imaging Holdings, Inc. Common Stock Strong Buy Raymond James Feb 2026 - Meyka
Lumexa Imaging (NASDAQ:LMRI) Raised to "Strong-Buy" at Raymond James Financial - MarketBeat
FinancialContentLumexa Imaging Holdings, Inc.Common Stock (Nasdaq:LMRI) Stock Quote - FinancialContent
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care - The Malaysian Reserve
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Adv - GuruFocus
Lumexa Imaging’s Dr. Kemp elected to RSNA board By Investing.com - Investing.com Canada
Lumexa Imaging Holdings, Inc.’s Quiet Period Set To End on January 20th (NASDAQ:LMRI) - Defense World
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March - Investing.com Nigeria
Lumexa Imaging Holdings, Inc. Announces Resignation of Chief Legal Officer and Corporate Secretary Julie Szeker, Effective March 13, 2026 - marketscreener.com
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March By Investing.com - Investing.com South Africa
Lumexa Imaging Announces Chief Legal Officer Resignation - TipRanks
Assessing Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Pullback - Yahoo Finance
Lumexa Imaging Holdings Grants $450,000 Transition Payment and Bonus to Departing Chief Legal Officer - Longbridge
LMRI: Global radiopharma leader drives growth with late-stage oncology pipeline and strategic expansion - TradingView — Track All Markets
Lumexa Imaging: Resilient Demand With Compounding Scale Moat (NASDAQ:LMRI) - Seeking Alpha
Lumexa Imaging Holdings, Inc.Common Stock (NQ: LMRI - FinancialContent
Lumexa Imaging Achieves Record De Novo Expansion in 2025 - Sahm
Lumexa Imaging Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Target Price Consensus and Analysts Recommendations | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Dividend historical data and projections - MarketScreener
Analysts Offer Insights on Technology Companies: Advanced Micro Devices (AMD) and Lumexa Imaging Holdings, Inc. (LMRI) - The Globe and Mail
Analysts Offer Insights on Technology Companies: Broadcom (AVGO), Lumexa Imaging Holdings, Inc. (LMRI) and Apple (AAPL) - The Globe and Mail
Lumexa Imaging Holdings: Leveraging Outpatient Growth and JV Model to Drive Premium-Valued Expansion and Deleveraging Upside - TipRanks
Lumexa Imaging Announces Participation in Upcoming January 2026 Investor Conference - BioSpace
Lumexa Imaging Announces Participation in Upcoming Investor Conf - GuruFocus
Lumexa Imaging Announces Participation in Upcoming Investor Conference - Finviz
Lumexa Imaging Holdings: Secular Tailwinds, High-Return Expansion, and Joint-Venture Model Support Buy Rating - TipRanks
Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO - One News Page
Deutsche Bank Initiates Lumexa Imaging at Buy With $22 Price Target - marketscreener.com
Deutsche Bank initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com Canada
JPMorgan Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Jefferies Initiates Lumexa Imaging at Buy With $23 Price Target - marketscreener.com
Barclays Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Leerink Partners Initiates Lumexa Imaging at Outperform With $23 Price Target - marketscreener.com
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
LMRI Archives - 24/7 Wall St.
Wells Fargo initiates Lumexa Imaging stock with Overweight rating By Investing.com - Investing.com Canada
Lumexa Imaging stock initiated with Outperform rating by William Blair - Investing.com
Lumexa Imaging Holdings: Capitalizing on Outpatient Imaging Tailwinds with Sustainable Growth and Attractive Risk-Reward - TipRanks
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Lumexa Imaging stock with Overweight rating, $23 target By Investing.com - Investing.com Canada
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com
Lumexa Imaging Holdings Inc (LMRI) 재무 분석
Lumexa Imaging Holdings Inc (LMRI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):